Raymond James Financial
AMIX

Raymond James Financial’s Autonomix Medical AMIX Stock Holding History

Raymond James Financial’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8
Closed -$254 – 6846
2025
Q2 		$254 Buy
+8
New +$287 ﹤0.01% 6755

Other funds holding AMIX

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

Raymond James Financial's AMIX Position: Q3 2025 in Review

Raymond James Financial sold out of Autonomix Medical (AMIX) in Q3 2025, closing a stake of 8 shares — an estimated $254 sold.

Raymond James Financial first reported a position in AMIX in Q2 2025 and held it in 1 quarter. The position peaked at $254 in Q2 2025. 14 funds tracked by Wall St. Rank hold AMIX as of Q3 2025.

  • Raymond James Financial reported no remaining Autonomix Medical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 8 Autonomix Medical shares in Q3 2025, an estimated $254.
  • Raymond James Financial first reported a position in Autonomix Medical in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Autonomix Medical position peaked at $254 in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Autonomix Medical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.